Independent Clinical Study Shows that BreatheRite™ MDI
Chamber Delivers Patient Medication More Efficiently.
Choose between the economical rigid or
• 22mm O.D. round mouthpiece fits any mask
collapsible holding chamber and enjoy
• Geometrically advanced chamber allows for
increased portability.
• Low resistance exhalation valve angles exhaled
• Inspiratory aperture eliminates the need for flow signal
Call today for Alliance Tech Medical’s complete line of COPD, respiratory, asthma
Help patients maintain their respiratory health with
management products, sanitizers, splash
potential efficient delivery of medication. shields, ventlab chambers and many other items. Connect with us online www.alliancetechmedical.com PARTICLE SIZE AND OUTPUT COMPARISON OF THE BREATHERITE AND AEROCHAMBER AEROSOL HOLDING CHAMBERS R. J. Perry B.S., W. Chiang and J.S. Ilowite M.D, SUNY at Stony Brook, NY 11794, California Measurements, CA 91024 and Winthrop-University Hospital, Mineola, NY 11501.
The BreatheRite (Ventlab Corp.)is a new aerosol holding chamber (HC), which has the advantage of col apsibility and increased portability, potential y improving compliance among patients that benefit from holding chambers but are reluctant to carry bulky devices outside their home. Prior to clinical use, new HC design characteristics are bench tested. Therefore we measure the aerosol particle size and output efficiency of the BreatheRite and also of the FDA approved AeroChamber® for comparison. Both devices were combined with beclomethasone, albuterol or cromlyn MDIs and tested in triplicate using previous published techniques (Kim, C.S. et al., ARRD 1985; 132:137- 142 & 1987; 135:157-164) of cascade impacation (for particle sizing) and filter sampling (for output efficiency). Cascade data was analyzed via log probability plot to determine the mass median aerodynamic diameter (MMAD)
BreatheRite in microns (µm) and efficiency data was calculated as the aerosol mass produced from each HC divided by the
MDI dose per puff and expressed as a percent. Results are summarized in the following table. Beclomethasone Abuterol
MMAD (µm)±SD BreatheRite™ 0.99 ± .07 1.62 ± .03 2.59 ± .09
Efficiency (%)±SD BreatheRite™ 74.6 ± .7.3 61.5 ± 4.6 53.5 ± 3.2 For the three drugs tested, our analysis demonstrated a 42% greater efficiency of the BreatheRite over the AeroChamber with nearly identical aerosol particle sizes. We believe that patients should have similar drug aerosol desposition patterns in the lung with either HC and a significantly higher inhaled drug dose via the BreatheRite. the clinical relevance of this data remains to be determined. Description Packaging
Infant (Small) Silicone Mask for Chamber
Infant (Small) Silicone Mask for Chamber
Pediatric (Medium) Silicone Mask for Chamber
Pediatric (Medium) Silicone Mask for Chamber
BreatheRite Chamber with Small Mask (Rigid)
BreatheRite Chamber with Medium Mask (Rigid)
BreatheRite Chamber with Large Mask (Rigid)
BreatheRite Chamber with Small Mask (Collapsible)
BreatheRite Chamber with Medium Mask (Collapsible)
BreatheRite Chamber with Large Mask (Collapsible)
PO Box 6024 / Granbury, TX 760491.800.848.8923 / 817.326.6357 Fax: 817.326.2182 / www.alliancetechmedical.com
Eastern Office 302.838.2638 Central Office 630.910.0993 Southern Office 817.326.3183 Western Office 800.848.8923
BioLineRx Signs Exclusive License Agreement with Yissum for Oral Phase II Ready Treatment BL-7040 for Inflammatory Bowel Disease Jerusalem, June 27, 2011 - BioLineRx (TASE:BLRX), a biopharmaceutical drug development company, and Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that they have sign
Azilect nyhetsbrev nr 3 Vel overstått sommerferie! “Treatment decisions in newly diagnosed Parkinson’s disease” Vel tilbake på arbeid venter pasienter, kolleger og legemiddelindustrien på din tid betydningsfull i kraft av din kompetanse og hos den enkelte pasient er så forskjellig, Det er selvfølgelig individuelt, men noen bør man tenke på ved valg